Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System

In conclusion, extreme PC transfusion dependency during the first cycle of AZA and very poor risk cytogenetics are important prognostic factors in AZA monotherapy for MDS.PMID:38192677 | PMC:PMC10773215 | DOI:10.3892/ol.2023.14193

Source: Oncology Letters - January 9, 2024 Category: Cancer & Oncology Authors: Yu Inoue Haruya Okamoto Akihiro Miyashita Yuka Kawaji-Kanayama Shotaro Chinen Takahiro Fujino Taku Tsukamoto Yuji Shimura Shinsuke Mizutani Hiroto Kaneko Saeko Kuwahara-Ota Shin-Ichi Fuchida Daichi Nishiyama Koichi Hirakawa Hitoji Uchiyama Nobuhiko Uoshim Source Type: research